This review highlights the temporal changes, age-dependent inequalities, and clinical challenges in providing guideline-recommended therapies for older adults with acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
Persistent age-related gaps in ACS therapy warrant clinician vigilance; leaves open targeted trials to close inequalities in older adults.
Advancing age is a risk factor for the development of coronary artery disease and is an important indicator of outcome after acute coronary syndrome. As the number of older adults increases, the burden of cardiovascular disease is set to grow particularly as older adults remain disadvantaged in the delivery of acute cardiac care. This article reviews the temporal changes in the provision of guideline recommended therapies for the management of acute coronary syndrome, discusses reasons for age-dependent inequalities in care and the challenges facing clinicians.
No takes yet. Share an insight, caveat, or question.
Saunderson et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: